Literature DB >> 2471978

Expression of immunogenic epitopes of hepatitis B surface antigen with hybrid flagellin proteins by a vaccine strain of Salmonella.

J Y Wu1, S Newton, A Judd, B Stocker, W S Robinson.   

Abstract

A nonvirulent Salmonella dublin flagellin-negative, aromatic-dependent live vaccine strain has been used to express hepatitis B virus surface antigen epitopes in an immunogenic form. The envelope proteins of the virion are encoded by the S gene, which contains the pre-S1, pre-S2, and S coding regions. Synthetic oligonucleotides corresponding to amino acid residues S-(122-137) and pre-S2-(120-145) were inserted in-frame into the hypervariable region of a cloned Salmonella flagellin gene, and the recombinant plasmids were introduced into a flagellin-negative aroA mutant live vaccine strain of S. dublin, SL5928. The flagellin gene was expressed in bacteria carrying the plasmids as detected by immunoblotting with anti-flagellin (H1-d) serum. Both the S and pre-S2 epitopes were detected in bacteria carrying the relevant plasmid by immunoblotting with anti-HBs (antibody to hepatitis B virus surface antigen) and anti-peptide antisera. Animals immunized intramuscularly or orally with the live recombinant bacteria developed antibodies specific to these hepatitis B virus epitopes as detected by ELISA.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2471978      PMCID: PMC287346          DOI: 10.1073/pnas.86.12.4726

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  25 in total

1.  Protection against experimental salmonellosis in mice and sheep by immunisation with aromatic-dependent Salmonella typhimurium.

Authors:  T K Mukkur; G H McDowell; B A Stocker; A K Lascelles
Journal:  J Med Microbiol       Date:  1987-08       Impact factor: 2.472

2.  Prediction of protein antigenic determinants from amino acid sequences.

Authors:  T P Hopp; K R Woods
Journal:  Proc Natl Acad Sci U S A       Date:  1981-06       Impact factor: 11.205

3.  Chemically synthesized peptides predicted from the nucleotide sequence of the hepatitis B virus genome elicit antibodies reactive with the native envelope protein of Dane particles.

Authors:  R A Lerner; N Green; H Alexander; F T Liu; J G Sutcliffe; T M Shinnick
Journal:  Proc Natl Acad Sci U S A       Date:  1981-06       Impact factor: 11.205

4.  Isolation and characterization of Gal E mutant Ty 21a of Salmonella typhi: a candidate strain for a live, oral typhoid vaccine.

Authors:  R Germanier; E Füer
Journal:  J Infect Dis       Date:  1975-05       Impact factor: 5.226

5.  Antibody to hepatitis B surface antigen after a single inoculation of uncoupled synthetic HBsAg peptides.

Authors:  G R Dreesman; Y Sanchez; I Ionescu-Matiu; J T Sparrow; H R Six; D L Peterson; F B Hollinger; J L Melnick
Journal:  Nature       Date:  1982-01-14       Impact factor: 49.962

6.  Aromatic-dependent Salmonella typhimurium are non-virulent and effective as live vaccines.

Authors:  S K Hoiseth; B A Stocker
Journal:  Nature       Date:  1981-05-21       Impact factor: 49.962

7.  Simultaneous induction of antigen-specific IgA helper T cells and IgG suppressor T cells in the murine Peyer's patch after protein feeding.

Authors:  L K Richman; A S Graeff; R Yarchoan; W Strober
Journal:  J Immunol       Date:  1981-06       Impact factor: 5.422

8.  Chemically synthesized peptides of hepatitis B surface antigen duplicate the d/y specificities and induce subtype-specific antibodies in chimpanzees.

Authors:  J L Gerin; H Alexander; J W Shih; R H Purcell; G Dapolito; R Engle; N Green; J G Sutcliffe; T M Shinnick; R A Lerner
Journal:  Proc Natl Acad Sci U S A       Date:  1983-04       Impact factor: 11.205

9.  The newly licensed hepatitis B vaccine. Characteristics and indications for use.

Authors:  S Krugman
Journal:  JAMA       Date:  1982-04-09       Impact factor: 56.272

10.  Two distinct antigen-specific suppressor factors induced by the oral administration of antigen.

Authors:  J A Mattingly; J M Kaplan; C A Janeway
Journal:  J Exp Med       Date:  1980-09-01       Impact factor: 14.307

View more
  13 in total

Review 1.  Oral immunization using live attenuated Salmonella spp. as carriers of foreign antigens.

Authors:  L Cárdenas; J D Clements
Journal:  Clin Microbiol Rev       Date:  1992-07       Impact factor: 26.132

2.  Expression and immunogenicity of a streptococcal M protein epitope inserted in Salmonella flagellin.

Authors:  S M Newton; M Kotb; T P Poirier; B A Stocker; E H Beachey
Journal:  Infect Immun       Date:  1991-06       Impact factor: 3.441

Review 3.  Recombinant avirulent salmonellae as oral vaccine carriers.

Authors:  F Schödel
Journal:  Infection       Date:  1992 Jan-Feb       Impact factor: 3.553

Review 4.  Effects of flagellin on innate and adaptive immunity.

Authors:  Anna N Honko; Steven B Mizel
Journal:  Immunol Res       Date:  2005       Impact factor: 2.829

5.  Evaluation in volunteers of a candidate live oral attenuated Salmonella typhi vector vaccine.

Authors:  D M Hone; C O Tacket; A M Harris; B Kay; G Losonsky; M M Levine
Journal:  J Clin Invest       Date:  1992-08       Impact factor: 14.808

6.  Hypervariable region IV of Salmonella gene fliCd encodes a dominant surface epitope and a stabilizing factor for functional flagella.

Authors:  X S He; M Rivkina; B A Stocker; W S Robinson
Journal:  J Bacteriol       Date:  1994-04       Impact factor: 3.490

7.  Structural and antigenic characteristics of Campylobacter coli FlaA flagellin.

Authors:  M E Power; P Guerry; W D McCubbin; C M Kay; T J Trust
Journal:  J Bacteriol       Date:  1994-06       Impact factor: 3.490

8.  Molecular analyses of the Salmonella g. . . flagellar antigen complex.

Authors:  B J Masten; T M Joys
Journal:  J Bacteriol       Date:  1993-09       Impact factor: 3.490

9.  Host and bacterial factors affecting induction of immune responses to flagellin expressed by attenuated Salmonella vaccine strains.

Authors:  M E Sbrogio-Almeida; T Mosca; L M Massis; I A Abrahamsohn; L C S Ferreira
Journal:  Infect Immun       Date:  2004-05       Impact factor: 3.441

10.  Antibodies against Marinobacter algicola and Salmonella typhimurium flagellins do not cross-neutralize TLR5 activation.

Authors:  Raul Terron-Exposito; Benoit Dudognon; Inmaculada Galindo; Jose I Quetglas; Julio M Coll; Jose M Escribano; Eduardo Gomez-Casado
Journal:  PLoS One       Date:  2012-11-14       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.